Printer Friendly
The Free Library
19,122,083 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Laboratorio Elea Signs Distribution Agreement With Chiron Behring GmbH & Co.


Business Editors/Hi-Tech Writers

BUENOS AIRES Buenos Aires (bwā`nəs ī`rēz, âr`ēz, Span. bwā`nōs ī`rās), city and federal district (1991 pop. , Argentina--(BUSINESS WIRE)--Jan. 3, 2001

Laboratorio Elea SACIFyA, a privately held Argentinean pharmaceutical company, signed a distribution agreement with Chiron Behring GmbH & Co on September 29th, 2000.

Under the distribution agreement, the marketing rights of the flu vaccine


    The flu vaccine is a vaccine to protect against the highly variable influenza virus.

    The annual flu kills an estimated 36,000 people in the United States.
     Berigrippina(tm) shall be transferred to Elea from Aventis Pharma, who has been marketing the product so far.

    The agreement also includes DPT Vaccine DPT vaccine
    n.
    See DTP vaccine.
     Behring, DT Vaccine DT vaccine Vaccinology A diphtheria and tetanus vaccine that does not protect from pertussis; it is reserved for persons with adverse reactions to a DPT shot or a personal or family history of a seizure disorder or brain disease  Behring, RABIPUR and Td Vaccine Behring.

    Regarding Tetanol(tm) (tetanus vaccine tetanus vaccine
    n. Abbr. T
    Tetanus toxoids vaccine.


    tetanus vaccine,
    n one of several vaccinations used to immunize against tetanus (lockjaw).
    ), Aventis Pharma shall be responsible for its marketing till March 31st, when the product shall be transferred to Laboratorio Elea.

    "We are pleased to be a partner of Chiron Behring GmbH & Co," stated Isaias Drajer, Elea's president. "These products fit our strategy perfectly and complete our vaccines portfolio with strong brands widely recognized by the medical community in Argentina."

    Chiron Behring GmbH & Co is a Marburg based Vaccines Company, subsidiary of Chiron Corporation Chiron Corporation was a multinational biotechnology firm based in Emeryville, California that was acquired by Novartis International AG on April 20 2006. It had offices and facilities in eighteen countries on five continents. . The company, dedicated to supplying and developing new vaccine products for adults and children, is a market leader in Germany. The company also sells its products to multinational health organizations and local distributors around the world. For more information about Chiron, visit the company's Web site at http://www.chiron.com.

    Laboratorio ELEA is a Buenos Aires based pharmaceutical company with a sales structure covering all the country. Elea focuses in two main business areas: Women's Health Women's Health Definition

    Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues.
     and Infectious Diseases. For more information about Laboratorio Elea, visit the company's Web site at http://www.laboratorioelea.com.ar.

    For further information, please contact:

    Isaias Drajer

    President

    e-mail: drajeri@gymsa.com.ar

    Laboratorio Elea SACIFyA

    www.laboratorioelea.com.ar

    Tel: 54-11-4379-4300 / 4341

    Fax: 54-11-4379-4260
    COPYRIGHT 2001 Business Wire
    No portion of this article can be reproduced without the express written permission from the copyright holder.
    Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

     Reader Opinion

    Title:

    Comment:



     

    Article Details
    Printer friendly Cite/link Email Feedback
    Publication:Business Wire
    Geographic Code:4EUFR
    Date:Jan 3, 2001
    Words:278
    Previous Article:Sir Speedy's Global Digital Network Expands Into Eastern Europe With First Site in Poland.
    Next Article:Infotopia Readies BodyRocker for Full Rollout; Testing Exceeds Industry Average.



    Related Articles
    Chiron to Purchase Interest in Hoechst's Behringwerke Vaccine Business.
    Chiron and Behringwerke Complete Joint Venture in Vaccines, to be Known as Chiron Behring.
    Chiron Behring Forms Marketing Agreement For Germany With North American Vaccine.
    Chiron Completes Acquisition of Vaccines Business From Hoechst AG.
    Cardiovascular Diagnostics and Chiron Diagnostics Sign Global Distribution Agreement.
    Laboratorio Elea Announces an Important Growth of the Company Within the Argentinean Women's Health Market.
    HUMAN GENOME/AVENTIS BEHRING TO DEVELOP PLASMA PROTEIN.
    PLAYING LEGAL FOOTBALL\Seattle defends its NFL territory.
    L.A. WON'T BE LANDING SEAHAWKS : MICROSOFT'S ALLEN GAINS OPTION TO BUY CLUB AND REMAIN IN SEATTLE.
    LION GETS NEW AND UPGRADED LICENSES FOR SRS.

    Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles